NCT05344742 2022-04-25
A Study of Mitoxantrone Hydrochloride Liposome Injection Combination Therapy in Chinese Patients With Advanced Solid Tumors
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Phase 1 Unknown
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Huabo Biopharm Co., Ltd.
National Cancer Centre, Singapore
Genta Incorporated
Rambam Health Care Campus